Targets to Therapies: Neuroinflammation Target Validation

About this funding opportunity

Animations

Home Page

Save for later

Targets to Therapies: Neuroinflammation Target Validation

Donate Now

Funding Opportunities Save for later Targets to Therapies: Neuroinflammation Target Validation

Objective:

The Targets to Therapies Program seeks to build a robust evidence base for neuroinflammation targets with high potential relevance to Parkinson’s disease. Funding will support projects to clarify human relevance, define mechanism in Parkinson's-relevant contexts, establish target engagement, or develop enabling tools and assays.

The Targets to Therapies Program supports: Target modulation in cell and animal models to determine efficacy on PD phenotypes Generate evidence linking target biology to PD patient samples Clarifying the therapeutic mechanism of action Identify and test biomarkers to aid preclinical therapeutic validation and patient stratification Biological safety through animal model characterization

When considering proposals submitted to this program, MJFF prioritizes those that: Directly address known target gaps (e.g., human modulation, biomarker linkage, mechanism in α-syn biology and related PD pathology) Generate reproducible, translatable data that advances the target toward a therapeutic decision point

For this round, MJFF will not consider proposals focused on the following: Broad immunology discovery without a defined target Therapeutic development programs not directly tied to target validation

Please note that MJFF has an Open Science Policy which governs research outputs (such as preprints, journal articles, data, code, and software) resulting from MJFF-funded work. The Open Science Policy applies to this funding program and includes specific rules, timing, and format for the return of those research outputs and requires them to be shared openly, to be free to access, and with persistent identifiers. Please contact openscience@michaeljfox.org for questions about the Open Science Policy.

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.

I Understand

a17495660521.cdn.optimizely.com a17495660521.cdn.optimizely.com is blocked

This page has been blocked by an extension Try disabling your extensions.

ERR_BLOCKED_BY_CLIENT

Reload

This page has been blocked by an extension

Topic areas: Life Sciences and Health.

Funding amount

This grant provides Varies in funding.

Deadline

Applications are accepted on a rolling basis; there is no single fixed deadline.

Who can apply

This opportunity is open to the following applicant types:

• Not specified by the program.

Eligibility

The program did not publish a separate eligibility statement. See the official opportunity page for the full eligibility criteria.

Agency

Targets to Therapies: Neuroinflammation Target Validation is administered by Michael J. Fox Foundation (MJFF), listed via Michael J. Fox Foundation.